Radboud University Medical Center and Maastricht UMC+ published clinical long-read genome sequencing work using a comprehensive rare-disease test design, aiming to improve accuracy and efficiency versus standard-of-care approaches. The test approach leverages long-read sequencing to better resolve complex variant biology, including phasing and novel variant detection. The diagnostic strategy is positioned as a workflow consolidation tool as centers scale first-tier testing in additional indications. The publication reinforces how long-read adoption is moving from research pilots into broader clinical operations.